Real-World Solutions to Advance the Prompt and Accurate Diagnosis of Chronic Graft-Versus-Host Disease
CE Information
0.25 CME credits (0.25 pharmacology)Completion Time
25 minutesAvailable Until
March 26, 2026Posted By
PRIME Continuing Medical Education

Navigate
Overview
Specialties
OncologySubspecialties
OncologyClinical Topics
Pain and Primary CareThis comprehensive program tailored to provide personalized education based on your existing knowledge on the latest evidence in the diagnosis of chronic graft-versus-host disease (cGVHD). Through this program, you'll gain insights into evaluating clinical data to enhance your recognition of signs and symptoms of cGVHD as well as selection and interpretation of appropriate diagnostic tests to make a prompt, accurate diagnosis, avoiding unnecessary delays and misdiagnosis, which often occur in clinical practice, and ultimately improving patient outcomes and quality of life.
Learning Objectives
- Apply the latest clinical guidelines and diagnostic criteria for cGVHD to facilitate timely and accurate diagnosis
- Assess patient-centered perspectives concerning the impact of cGVHD diagnosis and disease burden to guide treatment decisions
CE Information
This activity offers 0.25 CME credits (0.25 pharmacology) to attendees.
- 0.25 CME/CE for Physicians (ACCME)
- 0.25 CME/CE for Physician Assistants (AAPA)
- 0.25 CH/CE for Nurse Practitioners (AANP)
- 0.25 CPE for Pharmacists (ACPE + NABP)
- 0.25 CNE for Nurses (ANCC)
Disclosures
This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Sanofi US.
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.
Log in and start activity